AwardedCzechiaGoodsCZK 488,616,000
LP pro CNS - Tafamidis III.
- Published
- Published 16 April 2026
- Deadline
- Closed 18 May 2026
Overview
The Institute of Clinical and Experimental Medicine procured regular supplies of pharmaceutical products containing tafamidis (ATC N07XX08) for treating patients in approved indications. PHOENIX lékárenský velkoobchod, s.r.o. was awarded the contract on 26 May 2026 for 289,344,216 CZK.
Key details
- Country
- Czechia
- Status
- Awarded
- Category
- Goods
- Estimated value
- CZK 488,616,000
- Procedure
- Open
- SME suitable
- Yes
- Published
- 16 April 2026
- Deadline
- Closed
Medicinal products for the nervous system
Award outcome
- Awarded value
- CZK 289,344,216
- Award date
- 26 May 2026
- Contract period
- 14 July 2026 → 17 July 2030
- PHOENIX lékárenský velkoobchod, s.r.o.
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
26 June 2026
Contract Notice
16 April 2026
Contracting authority
Institut klinické a experimentální medicíny
Procuring entityPraha, Czechia
Authority website ↗
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.